Industry

Nearly half of parents report their children have experienced increased anxiety or have lost friendships; sleep and eating disorders more than double NEW YORK–(BUSINESS WIRE)–A national survey of parents conducted by Elemy (https://www.elemy.com/) the nationwide provider of childhood behavioral and mental healthcare, revealed deeply concerning impacts the COVID-19 pandemic has had on childhood mental health. … [Read more…]

AMSTERDAM–(BUSINESS WIRE)–VectorY Therapeutics, a biotech company focusing on the development of innovative gene therapy approaches for the treatment of muscular and neurodegenerative disorders through vectorized antibodies, today announces presentation of a poster at the European Network to Cure ALS (ENCALS) Annual Meeting at the University of Edinburgh on 1-3 June, 2022. Members of the VectorY … [Read more…]

CEO Giroir announces Altesa’s IND for vapendavir has the FDA green light for clinical study at AdvanSE Conference ATLANTA–(BUSINESS WIRE)–Altesa BioSciences, Inc. (Altesa), a clinical-stage biopharmaceutical company developing and commercializing novel antiviral drugs against common respiratory viruses and global viral threats, has U.S. Food & Drug Administration approval to proceed with a clinical study of … [Read more…]

Special Celebration at Azusa Pacific University on June 4 to Feature Star-Studded Talent Lineup, Led by ABC7 News Anchor Phillip Palmer LOS ANGELES–(BUSINESS WIRE)–#2022DonateLifeRunWalk–Celebrating 20 years of inspiring local communities to donate life, OneLegacy’s 2022 Donate Life Run/Walk will host an in-person event on June 4 at Azusa Pacific University’s soccer fields. With a new … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “North America Clinical Trials Market 2021-2031 by Product Category, Phase, Design, Service Type, Indication, End User, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. North America clinical trials market is projected to grow by 6.9% annually in the forecast period and reach $39,268.7 million by 2031, driven … [Read more…]

BILLERICA, Mass.–(BUSINESS WIRE)–OmniGuide Holdings (OGH) Today, the U.S. Food and Drug Administration cleared RevoLix™ HTL a family of pulsed and continuous wave Thulium YAG lasers is the foundation of RevoLix Therapy for urology patients undergoing BPH and Stone Management procedures. “The FDA’s clearance reflects our confidence in our unique RevoLix™ HTL therapy and our efforts … [Read more…]

MONTREAL–(BUSINESS WIRE)–On March 16, 2022, Medisca, a global supplier of pharmaceutical ingredients and equipment, entered into an exclusive agreement with SUANFARMA, a European-based manufacturer and distributor of pharmaceutical ingredients, for the global supply and distribution of Thyroid Powder, USP, by leveraging its exclusive partnership with pharmaceutical manufacturer, Sichuan Deebio Pharmaceutical Co., Ltd (Deebio). “Partnering with … [Read more…]

30 abstracts highlighting key data encompassing the Company’s broad oncology clinical portfolio to be presented Not intended for US-, Canada- or UK-based media DARMSTADT, Germany–(BUSINESS WIRE)–Merck, a leading science and technology company, today announced the latest research representing the Company’s innovative oncology portfolio has been accepted for presentation at this year’s American Society of Clinical … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Patricia Will, Founder and CEO of Belmont Village Senior Living, moderated a webinar entitled “Resilience and Wisdom in Senior Housing Communities” presented by Dr. Dilip V. Jeste, M.D., a renowned geriatric neuro-psychiatrist and Director of the Sam and Rose Stein Institute for Research on Aging at the University of California San Diego. The … [Read more…]

30 abstracts highlighting key data encompassing the Company’s broad oncology clinical portfolio to be presented ROCKLAND, Mass.–(BUSINESS WIRE)–Not intended for UK-based media EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany, in the US and Canada, today announced the latest research representing the Company’s innovative oncology portfolio has been accepted for presentation at this … [Read more…]